▶ 調査レポート

組み換えヒトエンドスタチンのヨーロッパ市場2017

• 英文タイトル:Europe Recombinant Human Endostatin Market Report 2017

QYResearchが調査・発行した産業分析レポートです。組み換えヒトエンドスタチンのヨーロッパ市場2017 / Europe Recombinant Human Endostatin Market Report 2017 / A042120484資料のイメージです。• レポートコード:A042120484
• 出版社/出版日:QYResearch / 2017年3月10日
• レポート形態:英文、PDF、101ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥409,500 (USD3,900)▷ お問い合わせ
  Enterprise¥819,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、組み換えヒトエンドスタチンのヨーロッパ市場について調査・分析し、組み換えヒトエンドスタチンのヨーロッパ市場概観、組み換えヒトエンドスタチンの種類別市場分析、用途別市場分析、組み換えヒトエンドスタチンのヨーロッパ市場規模予測、関連企業分析、関連企業情報、価格情報、販売動向、ヨーロッパ市場動向、貿易動向、市場環境分析情報などを含め、以下の構成でお届けいたします。

・組み換えヒトエンドスタチンのヨーロッパ市場概観
・組み換えヒトエンドスタチンの種類別市場規模
・組み換えヒトエンドスタチンの用途別市場規模
・組み換えヒトエンドスタチンのヨーロッパ市場規模
・組み換えヒトエンドスタチンのヨーロッパ市場予測
・組み換えヒトエンドスタチンの製造メーカー分析
・組み換えヒトエンドスタチンのメーカー別生産量
・組み換えヒトエンドスタチンのメーカー別市場シェア
・組み換えヒトエンドスタチンの価格動向・価格分析
・組み換えヒトエンドスタチンの販売(売上高)動向
・組み換えヒトエンドスタチンの貿易(輸出・輸入)動向
・組み換えヒトエンドスタチンの産業チェーン分析
・組み換えヒトエンドスタチンのマーケティング戦略分析
・組み換えヒトエンドスタチンの販売業者(代理店)リスト
・組み換えヒトエンドスタチンの市場環境分析
...

Notes:Sales, means the sales volume of Recombinant Human Endostatin
Revenue, means the sales value of Recombinant Human Endostatin

This report studies sales (consumption) of Recombinant Human Endostatin in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Biocon
Mabtech
Novartis
Fujifilm Kyowa Kirin Biologics
Enzon Pharmaceuticals
Genexine
Hetero Drugs
Onyx Pharmaceuticals
Intas Pharmaceuticals

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Recombinant Human Endostatin in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by application, this report focuses on sales, market share and growth rate of Recombinant Human Endostatin in each application, can be divided into
Application 1
Application 2

レポート目次

Table of Contents

Europe Recombinant Human Endostatin Market Report 2017
1 Recombinant Human Endostatin Overview
1.1 Product Overview and Scope of Recombinant Human Endostatin
1.2 Classification of Recombinant Human Endostatin
1.2.1 Type I
1.2.2 Type II
1.3 Application of Recombinant Human Endostatin
1.3.1 Application 1
1.3.2 Application 2
1.4 Recombinant Human Endostatin Market by Countries
1.4.1 Germany Status and Prospect (2012-2022)
1.4.2 France Status and Prospect (2012-2022)
1.4.3 UK Status and Prospect (2012-2022)
1.4.4 Russia Status and Prospect (2012-2022)
1.4.5 Italy Status and Prospect (2012-2022)
1.4.6 Spain Status and Prospect (2012-2022)
1.4.7 Benelux Status and Prospect (2012-2022)
1.5 Europe Market Size (Value and Volume) of Recombinant Human Endostatin (2012-2022)
1.5.1 Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2022)
1.5.2 Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)

2 Europe Recombinant Human Endostatin by Manufacturers, Type and Application
2.1 Europe Recombinant Human Endostatin Market Competition by Manufacturers
2.1.1 Europe Recombinant Human Endostatin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Recombinant Human Endostatin Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Recombinant Human Endostatin (Volume and Value) by Type
2.2.1 Europe Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)
2.2.2 Europe Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
2.3 Europe Recombinant Human Endostatin (Volume and Value) by Countries
2.3.1 Europe Recombinant Human Endostatin Sales and Market Share by Countries (2012-2017)
2.3.2 Europe Recombinant Human Endostatin Revenue and Market Share by Countries (2012-2017)
2.4 Europe Recombinant Human Endostatin (Volume) by Application

3 Germany Recombinant Human Endostatin (Volume, Value and Sales Price)
3.1 Germany Recombinant Human Endostatin Sales and Value (2012-2017)
3.1.1 Germany Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
3.1.2 Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
3.1.3 Germany Recombinant Human Endostatin Sales Price Trend (2012-2017)
3.2 Germany Recombinant Human Endostatin Sales and Market Share by Manufacturers
3.3 Germany Recombinant Human Endostatin Sales and Market Share by Type
3.4 Germany Recombinant Human Endostatin Sales and Market Share by Application

4 France Recombinant Human Endostatin (Volume, Value and Sales Price)
4.1 France Recombinant Human Endostatin Sales and Value (2012-2017)
4.1.1 France Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
4.1.2 France Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
4.1.4 France Recombinant Human Endostatin Sales Price Trend (2012-2017)
4.2 France Recombinant Human Endostatin Sales and Market Share by Manufacturers
4.3 France Recombinant Human Endostatin Sales and Market Share by Type
4.4 France Recombinant Human Endostatin Sales and Market Share by Application

5 UK Recombinant Human Endostatin (Volume, Value and Sales Price)
5.1 UK Recombinant Human Endostatin Sales and Value (2012-2017)
5.1.1 UK Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
5.1.2 UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
5.1.5 UK Recombinant Human Endostatin Sales Price Trend (2012-2017)
5.2 UK Recombinant Human Endostatin Sales and Market Share by Manufacturers
5.3 UK Recombinant Human Endostatin Sales and Market Share by Type
5.4 UK Recombinant Human Endostatin Sales and Market Share by Application

6 Russia Recombinant Human Endostatin (Volume, Value and Sales Price)
6.1 Russia Recombinant Human Endostatin Sales and Value (2012-2017)
6.1.1 Russia Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
6.1.2 Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
6.1.6 Russia Recombinant Human Endostatin Sales Price Trend (2012-2017)
6.2 Russia Recombinant Human Endostatin Sales and Market Share by Manufacturers
6.3 Russia Recombinant Human Endostatin Sales and Market Share by Type
6.4 Russia Recombinant Human Endostatin Sales and Market Share by Application

7 Italy Recombinant Human Endostatin (Volume, Value and Sales Price)
7.1 Italy Recombinant Human Endostatin Sales and Value (2012-2017)
7.1.1 Italy Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
7.1.2 Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
7.1.7 Italy Recombinant Human Endostatin Sales Price Trend (2012-2017)
7.2 Italy Recombinant Human Endostatin Sales and Market Share by Manufacturers
7.3 Italy Recombinant Human Endostatin Sales and Market Share by Type
7.4 Italy Recombinant Human Endostatin Sales and Market Share by Application

8 Spain Recombinant Human Endostatin (Volume, Value and Sales Price)
8.1 Spain Recombinant Human Endostatin Sales and Value (2012-2017)
8.1.1 Spain Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
8.1.2 Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
8.1.8 Spain Recombinant Human Endostatin Sales Price Trend (2012-2017)
8.2 Spain Recombinant Human Endostatin Sales and Market Share by Manufacturers
8.3 Spain Recombinant Human Endostatin Sales and Market Share by Type
8.4 Spain Recombinant Human Endostatin Sales and Market Share by Application

9 Benelux Recombinant Human Endostatin (Volume, Value and Sales Price)
9.1 Benelux Recombinant Human Endostatin Sales and Value (2012-2017)
9.1.1 Benelux Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
9.1.2 Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
9.1.9 Benelux Recombinant Human Endostatin Sales Price Trend (2012-2017)
9.2 Benelux Recombinant Human Endostatin Sales and Market Share by Manufacturers
9.3 Benelux Recombinant Human Endostatin Sales and Market Share by Type
9.4 Benelux Recombinant Human Endostatin Sales and Market Share by Application

10 Europe Recombinant Human Endostatin Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Recombinant Human Endostatin Product Type, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Biocon
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Recombinant Human Endostatin Product Type, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Mabtech
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Recombinant Human Endostatin Product Type, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Novartis
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Recombinant Human Endostatin Product Type, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 Fujifilm Kyowa Kirin Biologics
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Recombinant Human Endostatin Product Type, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Enzon Pharmaceuticals
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Recombinant Human Endostatin Product Type, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 Genexine
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Recombinant Human Endostatin Product Type, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Hetero Drugs
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Recombinant Human Endostatin Product Type, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Onyx Pharmaceuticals
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Recombinant Human Endostatin Product Type, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Intas Pharmaceuticals
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Recombinant Human Endostatin Product Type, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Intas Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview

11 Recombinant Human Endostatin Manufacturing Cost Analysis
11.1 Recombinant Human Endostatin Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Recombinant Human Endostatin

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Recombinant Human Endostatin Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Europe Recombinant Human Endostatin Market Forecast (2017-2022)
14.1 Germany Recombinant Human Endostatin Sales Forecast (2017-2022)
14.2 France Recombinant Human Endostatin Sales Forecast (2017-2022)
14.3 UK Recombinant Human Endostatin Sales Forecast (2017-2022)
14.4 Russia Recombinant Human Endostatin Sales Forecast (2017-2022)
14.5 Italy Recombinant Human Endostatin Sales Forecast (2017-2022)
14.6 Spain Recombinant Human Endostatin Sales Forecast (2017-2022)
14.7 Benelux Recombinant Human Endostatin Sales Forecast (2017-2022)
14.8 Europe Recombinant Human Endostatin Sales Forecast by Type (2017-2022)
14.9 Europe Recombinant Human Endostatin Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Recombinant Human Endostatin
Table Classification of Recombinant Human Endostatin
Figure Europe Sales Market Share of Recombinant Human Endostatin by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Recombinant Human Endostatin
Figure Europe Sales Market Share of Recombinant Human Endostatin by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure France Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Figure Europe Recombinant Human Endostatin Sales and Growth Rate (2012-2022)
Figure Europe Recombinant Human Endostatin Revenue and Growth Rate (2012-2022)
Table Europe Recombinant Human Endostatin Sales of Key Manufacturers (2015 and 2016)
Table Europe Recombinant Human Endostatin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Human Endostatin Sales Share by Manufacturers
Figure 2016 Recombinant Human Endostatin Sales Share by Manufacturers
Table Europe Recombinant Human Endostatin Revenue by Manufacturers (2015 and 2016)
Table Europe Recombinant Human Endostatin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Recombinant Human Endostatin Revenue Share by Manufacturers
Table 2016 Europe Recombinant Human Endostatin Revenue Share by Manufacturers
Table Europe Recombinant Human Endostatin Sales and Market Share by Type (2012-2017)
Table Europe Recombinant Human Endostatin Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Type (2012-2017)
Figure Europe Recombinant Human Endostatin Sales Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Endostatin Revenue and Market Share by Type (2012-2017)
Table Europe Recombinant Human Endostatin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Human Endostatin by Type (2012-2017)
Figure Europe Recombinant Human Endostatin Revenue Growth Rate by Type (2012-2017)
Table Europe Recombinant Human Endostatin Sales and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Endostatin Sales Share by Countries (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Countries (2012-2017)
Table Europe Recombinant Human Endostatin Revenue and Market Share by Countries (2012-2017)
Table Europe Recombinant Human Endostatin Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Recombinant Human Endostatin by Countries (2012-2017)
Table Europe Recombinant Human Endostatin Sales and Market Share by Application (2012-2017)
Table Europe Recombinant Human Endostatin Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Human Endostatin by Application (2012-2017)
Figure Germany Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Germany Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Germany Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Germany Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table Germany Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table Germany Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table Germany Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table Germany Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure France Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure France Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure France Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table France Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table France Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table France Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table France Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table France Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table France Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure UK Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure UK Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure UK Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table UK Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table UK Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table UK Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table UK Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table UK Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table UK Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure Russia Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Russia Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Russia Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Russia Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table Russia Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table Russia Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table Russia Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table Russia Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure Italy Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Italy Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Italy Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Italy Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table Italy Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table Italy Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table Italy Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table Italy Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure Spain Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Spain Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Spain Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Spain Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table Spain Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table Spain Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table Spain Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table Spain Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Figure Benelux Recombinant Human Endostatin Sales and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate (2012-2017)
Figure Benelux Recombinant Human Endostatin Sales Price Trend (2012-2017)
Table Benelux Recombinant Human Endostatin Sales by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Endostatin Market Share by Manufacturers (2015 and 2016)
Table Benelux Recombinant Human Endostatin Sales by Type (2015 and 2016)
Table Benelux Recombinant Human Endostatin Market Share by Type (2015 and 2016)
Table Benelux Recombinant Human Endostatin Sales by Application (2015 and 2016)
Table Benelux Recombinant Human Endostatin Market Share by Application (2015 and 2016)
Table Recombinant Human Endostatin Basic Information List
Table Pfizer Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Biocon Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Mabtech Basic Information List
Table Mabtech Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mabtech Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Fujifilm Kyowa Kirin Biologics Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Enzon Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Genexine Basic Information List
Table Genexine Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genexine Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hetero Drugs Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Onyx Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Recombinant Human Endostatin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Intas Pharmaceuticals Recombinant Human Endostatin Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Human Endostatin
Figure Manufacturing Process Analysis of Recombinant Human Endostatin
Figure Recombinant Human Endostatin Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Human Endostatin Major Manufacturers in 2015
Table Major Buyers of Recombinant Human Endostatin
Table Distributors/Traders List
Figure Germany Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure Germany Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure France Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure UK Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure Russia Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure Italy Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure Spain Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Endostatin Sales and Growth Rate Forecast (2017-2022)
Figure Benelux Recombinant Human Endostatin Revenue and Growth Rate Forecast (2017-2022)
Table Europe Recombinant Human Endostatin Sales Forecast by Type (2017-2022)
Table Europe Recombinant Human Endostatin Sales Forecast by Application (2017-2022)